U.S. stock indexes gave up an early gain and ended slightly lower following a mixed set of profit reports from giants like Google’s parent company and Eli Lilly. The S&P 500 slipped 0.3% Wednesday.

Cases with felony charges including attempted murder and wanton endangerment were among the indictments handed down by the October session of the Mercer County Grand Jury. The October Grand Jury ...

We had the pleasure to look after a Jack Russell puppy for two days, our dog Lilly fell in love with her at first sight and they became good friends. Jackie lives next door so we can visit her ...

Shares of Eli Lilly have gained considerably throughout 2024, thanks in large part to the company's success in diabetes and obesity care. Outside of weight loss, Eli Lilly has a major opportunity ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best medical stocks to buy now. The medical and healthcare industry is one of the ...

Upon a comprehensive analysis of Eli Lilly, the following trends can be discerned: The Price to Earnings ratio of 112.95 for this company is 4.17x above the industry average, indicating a premium ...

Our Grant Me Hope child this week is 15-year-old Lilly, who is "very kind and caring," according to the Michigan Adoption Resource Exchange. According to MARE, her kindness doesn't stop at humans ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value. Earlier this month, the FDA removed Lilly’s popular GLP-1 drug ...

WASHINGTON, DC - JANUARY 30: Women's equality activist Lilly Ledbetter after a news conference at ... [+] the U.S. Capitol January 30, 2019 in Washington, DC. House Democrats held a news ...

INDIANAPOLIS, Oct. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2024 financial results on Oct. 30, 2024. Lilly will also conduct a conference call ...

Eli Lilly has brought in billion-dollar revenue from its weight loss drugs -- but short supply has limited the revenue opportunity. The FDA earlier this month recognized Lilly’s progress in ...